InsiderTrades

Form 4 for LDOS Leidos

Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001628280-23-006853 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2023-03-07 2023-03-03+ LDOS Opiekun Deborah D. Chief Business Development A - Grant $0.00 +1,878 6,813 +38% $0
DI 2023-03-07 2023-03-04 LDOS Opiekun Deborah D. Chief Business Development F - Tax $97.30 -20 6,805 -0.3% -$1,946
DM 2023-03-07 2023-03-05+ LDOS Opiekun Deborah D. Chief Business Development F - Tax $97.30 -88 10.7K -0.8% -$8,562
D 2023-03-07 2023-03-03 LDOS Opiekun Deborah D. Chief Business Development A - Grant $0.00 +7,066 7,066 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-03 A A 1,869.99 $0.00 6,824.73 I By Key Executive Stock Deferral Plan — —
2 Common Common Stock 2023-03-04 F D 20 $97.30 6,804.73 I By Key Executive Stock Deferral Plan — —
3 Common Common Stock 2023-03-06 F D 41 $97.30 10,694.26 D — —
4 Common Common Stock 2023-03-05 F D 47 $97.30 10,735.26 D — —
5 Common Common Stock 2023-03-04 A A 8.32 $0.00 6,813.05 I By Key Executive Stock Deferral Plan — —
6 Derivative Stock Option (Right to Buy) 2023-03-03 A A 7,066 $0.00 7,066 D $96.95 · 2024-03-03 to 2030-03-02 7,066 Common Stock (F2) The options vest and become exercisable in 33 1/3% over three annual installments, beginning on March 3, 2024.